The periods of protection provided for in Articles 14(11) and 39(10) shall not apply to reference medicinal products for which an application for authorisation has been submitted before the date referred to in Article 90, second paragraph.
Art. 89 Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 20…
Judgment of the General Court (Second Chamber) of 15 September 2015. Novartis Europharm Ltd v European Commission.Decision
In support of its action, the applicant puts forward a single plea for annulment, alleging infringement of Article 10(1) of Directive 2001/83 and Article 13(4) of Regulation No 2309/93, read with Articles 14(11) and 89 of Regulation No …
15 Sep 2015 · 62012TJ0472
Arrêt du Tribunal (deuxième chambre) du 15 septembre 2015. Novartis Europharm Ltd contre Commission européenne.Decision
… alleging infringement of Article 10(1) of Directive 2001/83 and Article 13(4) of Regulation No 2309/93, read with Articles 14(11) and 89 of Regulation No 726/2004.
15 Sep 2015 · 62013TJ0067
Judgment of the Court (Eighth Chamber) of 28 June 2017. Novartis Europharm Ltd v European Commission.Decision
Article 89 of that regulation provides: ‘The periods of protection provided for [inter alia in Article 14(11)] shall not apply to reference medicinal products for which an application for authorisation has been submitted before [20 …
28 Jun 2017 · 62015CJ0629
Opinion of Advocate General Bobek delivered on 21 December 2016.Decision
Under Article 89 of Regulation No 726/2004 ‘the periods of protection provided for [in particular, in Article 14(11)] shall not apply to reference medicinal products for which an application for authorisation has been submitted before …
21 Dec 2016 · 62015CC0629
Judgment of the Court (Fourth Chamber) of 22 December 2010. European Commission v Republic of Poland.Decisionrelated
22 Dec 2010 · 62008CJ0385